Lipocine Inc. Profile Avatar - Palmy Investing

Lipocine Inc.

Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions …

Biotechnology
US, Salt Lake City [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of LPCN's Analysis
CIK: 1535955 CUSIP: 53630X104 ISIN: US53630X2036 LEI: - UEI: -
Secondary Listings
LPCN has no secondary listings inside our databases.